Gladstone Institutional Advisory LLC Lowers Stock Position in CVS Health Co. (NYSE:CVS)

Gladstone Institutional Advisory LLC reduced its stake in CVS Health Co. (NYSE:CVS) by 11.9% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 12,825 shares of the pharmacy operator’s stock after selling 1,731 shares during the quarter. Gladstone Institutional Advisory LLC’s holdings in CVS Health were worth $576,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors and hedge funds have also bought and sold shares of CVS. AMF Tjanstepension AB raised its stake in shares of CVS Health by 124.1% during the third quarter. AMF Tjanstepension AB now owns 61,744 shares of the pharmacy operator’s stock worth $3,882,000 after acquiring an additional 34,198 shares in the last quarter. Exchange Traded Concepts LLC raised its stake in shares of CVS Health by 61.9% during the third quarter. Exchange Traded Concepts LLC now owns 14,853 shares of the pharmacy operator’s stock worth $934,000 after acquiring an additional 5,679 shares in the last quarter. Creative Planning raised its stake in shares of CVS Health by 23.5% during the third quarter. Creative Planning now owns 250,891 shares of the pharmacy operator’s stock worth $15,776,000 after acquiring an additional 47,737 shares in the last quarter. nVerses Capital LLC purchased a new position in shares of CVS Health during the third quarter worth approximately $101,000. Finally, Secure Asset Management LLC raised its stake in shares of CVS Health by 38.4% during the third quarter. Secure Asset Management LLC now owns 29,247 shares of the pharmacy operator’s stock worth $1,839,000 after acquiring an additional 8,121 shares in the last quarter. 80.66% of the stock is owned by hedge funds and other institutional investors.

CVS Health Stock Performance

Shares of CVS stock opened at $65.71 on Friday. CVS Health Co. has a 12 month low of $43.56 and a 12 month high of $80.75. The stock has a market cap of $82.68 billion, a PE ratio of 16.68, a price-to-earnings-growth ratio of 0.60 and a beta of 0.61. The company has a current ratio of 0.80, a quick ratio of 0.59 and a debt-to-equity ratio of 0.80. The company’s fifty day moving average price is $50.90 and its 200-day moving average price is $56.01.

CVS Health (NYSE:CVS) last announced its earnings results on Wednesday, February 12th. The pharmacy operator reported $1.19 EPS for the quarter, beating analysts’ consensus estimates of $0.89 by $0.30. CVS Health had a net margin of 1.36% and a return on equity of 10.72%. On average, equities analysts expect that CVS Health Co. will post 5.14 EPS for the current fiscal year.

CVS Health Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Monday, February 3rd. Stockholders of record on Thursday, January 23rd were given a $0.665 dividend. This represents a $2.66 annualized dividend and a dividend yield of 4.05%. The ex-dividend date was Thursday, January 23rd. CVS Health’s dividend payout ratio is presently 67.51%.

Analysts Set New Price Targets

CVS has been the topic of several research reports. UBS Group decreased their price target on shares of CVS Health from $62.00 to $59.00 and set a “neutral” rating on the stock in a research note on Tuesday. Leerink Partners upgraded shares of CVS Health from a “market perform” rating to an “outperform” rating and raised their target price for the stock from $55.00 to $75.00 in a report on Thursday. Wells Fargo & Company raised their target price on shares of CVS Health from $68.00 to $73.00 and gave the stock an “overweight” rating in a report on Thursday. Royal Bank of Canada cut their target price on shares of CVS Health from $68.00 to $58.00 and set an “outperform” rating on the stock in a report on Friday, November 15th. Finally, Cantor Fitzgerald upgraded shares of CVS Health from a “neutral” rating to an “overweight” rating in a report on Wednesday. Four analysts have rated the stock with a hold rating, seventeen have issued a buy rating and one has issued a strong buy rating to the company. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $70.28.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.